Premium
Inhibitors of Endocannabinoid Degradation: Potential Therapeutics for Neurological Disorders
Author(s) -
Wendeler Michaela,
Kolter Thomas
Publication year - 2003
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.200301641
Subject(s) - endocannabinoid system , 2 arachidonoylglycerol , anxiolytic , pharmacology , degradation (telecommunications) , analgesic , neuroscience , medicine , chemistry , biology , cannabinoid receptor , anxiety , psychiatry , computer science , antagonist , receptor , telecommunications
Joint benefits: Selective inhibitors of endocannabinoid degradation have been developed, among them the shown carbamate, which exhibit anxiolytic and analgesic properties in laboratory animals.